*YEAR-END REPORT 2025: NEW CEO TAKES THE HELM - INITIATES THE NEXT PHASE OF ENZYMATICA'S INTERNATIONAL EXPANSION
*Q4 NET SALES REACHED SEK 18.3 (17.2) MILLION
*Q4 THE OPERATING RESULT TOTALED SEK -10.2 (-13.7) MILLION
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 18-FEB-202607:30:02.56 GMT